Mast cell mediators in tolerance

Current Opinion in Immunology

Volumn 22, Issue 5, 2010, Pages 643-648

  de Vries, Victor C ^a,c   Noelle, Randolph J ^a,b,c  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NORRIS COTTON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CARBOXYPEPTIDASE A; CHYMASE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HISTAMINE RECEPTOR; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LEUKOTRIENE B4; LEUKOTRIENE C4; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 4; MONOCYTE CHEMOTACTIC PROTEIN 5; MONOCYTE CHEMOTACTIC PROTEIN 6; PROSTAGLANDIN D2; PROSTAGLANDIN E2; TRANSFORMING GROWTH FACTOR ALPHA; TRYPTASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ANTINEOPLASTIC ACTIVITY; ASTHMA; BACTERIAL INFECTION; CELL FUNCTION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVITY; HELMINTHIASIS; HISTAMINE RELEASE; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; MAST CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ANIMALS; CYTOKINES; HUMANS; IMMUNE TOLERANCE; MAST CELLS;

EID: 78049311190     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.08.015     Document Type: Review

References (57)

1. Galli S.J., Grimbaldeston M., Tsai M. Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat Rev Immunol 2008, 8:478-486.
2. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 2006, 442:997-1002.
3. de Vries V.C., Pino-Lagos K., Elgueta R., Noelle R.J. The enigmatic role of mast cells in dominant tolerance. Curr Opin Organ Transpl 2009, 14:332-337.
4. de Vries V.C., Wasiuk A., Bennett K.A., Benson M.J., Elgueta R., Waldschmidt T.J., Noelle R.J. Mast cell degranulation breaks peripheral tolerance. Am J Transpl 2009, 9:2270-2280.
5. Sayed B.A., Christy A., Quirion M.R., Brown M.A. The master switch: the role of mast cells in autoimmunity and tolerance. Annu Rev Immunol 2008, 26:705-739.
6. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 2007, 8:1095-1104.
7. Mikita N., Kanazawa N., Yoshimasu T., Ikeda T., Li H.J., Yamamoto Y., Furukawa F. The protective effects of ultraviolet A1 irradiation on spontaneous lupus erythematosus-like skin lesions in MRL/lpr mice. Clin Dev Immunol 2009, 2009:673952.
8. Byrne S.N., Limon-Flores A.Y., Ullrich S.E. Mast cell migration from the skin to the draining lymph nodes upon ultraviolet irradiation represents a key step in the induction of immune suppression. J Immunol 2008, 180:4648-4655.
9. Depinay N., Hacini F., Beghdadi W., Peronet R., Mecheri S. Mast cell-dependent down-regulation of antigen-specific immune responses by mosquito bites. J Immunol 2006, 176:4141-4146.
10. Gillespie S.R., DeMartino R.R., Zhu J., Chong H.J., Ramirez C., Shelburne C.P., Bouton L.A., Bailey D.P., Gharse A., Mirmonsef P., et al. IL-10 inhibits Fc epsilon RI expression in mouse mast cells. J Immunol 2004, 172:3181-3188.
11. Gomez G., Ramirez C.D., Rivera J., Patel M., Norozian F., Wright H.V., Kashyap M.V., Barnstein B.O., Fischer-Stenger K., Schwartz L.B., et al. TGF-beta 1 inhibits mast cell Fc epsilon RI expression. J Immunol 2005, 174:5987-5993.
12. Kennedy Norton S., Barnstein B., Brenzovich J., Bailey D.P., Kashyap M., Speiran K., Ford J., Conrad D., Watowich S., Moralle M.R., et al. IL-10 suppresses mast cell IgE receptor expression and signaling in vitro and in vivo. J Immunol 2008, 180:2848-2854.
13. Pagliari C., Fernandes E.R., Guedes F., Alves C., Sotto M.N. Role of mast cells as IL10 producing cells in paracoccidioidomycosis skin lesions. Mycopathologia 2006, 162:331-335.
14. Fifadara N.H., Aye C.C., Raghuwanshi S.K., Richardson R.M., Ono S.J. CCR1 expression and signal transduction by murine BMMC results in secretion of TNF-alpha, TGFbeta-1 and IL-6. Int Immunol 2009, 21:991-1001.
15. Luo X., Tarbell K.V., Yang H., Pothoven K., Bailey S.L., Ding R., Steinman R.M., Suthanthiran M. Dendritic cells with TGF-beta1 differentiate naive CD4+CD25-T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 2007, 104:2821-2826.
16. Jarnicki A.G., Lysaght J., Todryk S., Mills K.H. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 2006, 177:896-904.
17. Shiota N, Nishikori Y, Kakizoe E, Shimoura K, Niibayashi T, Shimbori C, Tanaka T, Okunishi H: Pathophysiological role of skin mast cells in wound healing after scald injury: study with mast cell-deficient W/W(V) mice. Int Arch Allergy Immunol 2010, 151:80-88.
18. Suto H., Nakae S., Kakurai M., Sedgwick J.D., Tsai M., Galli S.J. Mast cell-associated TNF promotes dendritic cell migration. J Immunol 2006, 176:4102-4112.
19. Shelburne C.P., Nakano H., St John A.L., Chan C., McLachlan J.B., Gunn M.D., Staats H.F., Abraham S.N. Mast cells augment adaptive immunity by orchestrating dendritic cell trafficking through infected tissues. Cell Host Microbe 2009, 6:331-342.
20. Ogawa Y., Duru E.A., Ameredes B.T. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med 2008, 8:437-445.
21. Nakae S., Ho L.H., Yu M., Monteforte R., Iikura M., Suto H., Galli S.J. Mast cell-derived TNF contributes to airway hyperreactivity, inflammation, and TH2 cytokine production in an asthma model in mice. J Allergy Clin Immunol 2007, 120:48-55.
22. Shen H., Goldstein D.R. IL-6 and TNF-alpha synergistically inhibit allograft acceptance. J Am Soc Nephrol 2009, 20:1032-1040.
23. Verginis P., Li H.S., Carayanniotis G. Tolerogenic semimature dendritic cells suppress experimental autoimmune thyroiditis by activation of thyroglobulin-specific CD4+CD25+ T cells. J Immunol 2005, 174:7433-7439.
24. Bluml S., Binder N.B., Niederreiter B., Polzer K., Hayer S., Tauber S., Schett G., Scheinecker C., Kollias G., Selzer E., et al. Anti-inflammatory effects of TNF on hematopoietic cells in the development of erosive arthritis. Arthritis Rheum. 2010, 62(6):1608-1619.
25. Ernandez T., Mayadas T.N. Immunoregulatory role of TNFalpha in inflammatory kidney diseases. Kidney Int 2009, 76:262-276.
26. Simons J.W., Sacks N. Granulocyte-macrophage colony-stimulating factor-transduced allogeneic cancer cellular immunotherapy: the GVAX vaccine for prostate cancer. Urol Oncol 2006, 24:419-424.
27. Berger T.G., Schulze-Koops H., Schafer M., Muller E., Lutz M.B. Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro. PLoS One 2009, 4:e6645.
28. Dolcetti L, Peranzoni E, Ugel S, Marigo I, Fernandez Gomez A, Mesa C, Geilich M, Winkels G, Traggiai E, Casati A, et al.: Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. Eur J Immunol 40:22-35.
29. Ganesh B.B., Cheatem D.M., Sheng J.R., Vasu C., Prabhakar B.S. GM-CSF-induced CD11c+CD8a-dendritic cells facilitate Foxp3+ and IL-10+ regulatory T cell expansion resulting in suppression of autoimmune thyroiditis. Int Immunol 2009, 21:269-282.
30. Pejler G., Abrink M., Ringvall M., Wernersson S. Mast cell proteases. Adv Immunol 2007, 95:167-255.
31. Pang L., Nie M., Corbett L., Sutcliffe A., Knox A.J. Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities. J Immunol 2006, 176:3788-3795.
32. Mellon M.B., Frank B.T., Fang K.C. Mast cell alpha-chymase reduces IgE recognition of birch pollen profilin by cleaving antibody-binding epitopes. J Immunol 2002, 168:290-297.
33. Rauter I., Krauth M.T., Flicker S., Gieras A., Westritschnig K., Vrtala S., Balic N., Spitzauer S., Huss-Marp J., Brockow K., et al. Allergen cleavage by effector cell-derived proteases regulates allergic inflammation. FASEB J 2006, 20:967-969.
34. Rauter I., Krauth M.T., Westritschnig K., Horak F., Flicker S., Gieras A., Repa A., Balic N., Spitzauer S., Huss-Marp J., et al. Mast cell-derived proteases control allergic inflammation through cleavage of IgE. J Allergy Clin Immunol 2008, 121:197-202.
35. Aslam A., Quinn P., McIntosh R.S., Shi J., Ghumra A., McKerrow J.H., Bunting K.A., Dunne D.W., Doenhoff M.J., Morrison S.L., et al. Proteases from Schistosoma mansoni cercariae cleave IgE at solvent exposed interdomain regions. Mol Immunol 2008, 45:567-574.
36. McKerrow J.H., Caffrey C., Kelly B., Loke P., Sajid M. Proteases in parasitic diseases. Annu Rev Pathol 2006, 1:497-536.
37. Waern I., Jonasson S., Hjoberg J., Bucht A., Abrink M., Pejler G., Wernersson S. Mouse mast cell protease 4 is the major chymase in murine airways and has a protective role in allergic airway inflammation. J Immunol 2009, 183:6369-6376.
38. Shin K., Watts G.F., Oettgen H.C., Friend D.S., Pemberton A.D., Gurish M.F., Lee D.M. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J Immunol 2008, 180:4885-4891.
39. Thakurdas S.M., Melicoff E., Sansores-Garcia L., Moreira D.C., Petrova Y., Stevens R.L., Adachi R. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J Biol Chem 2007, 282:20809-20815.
40. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., Tsai M., Galli S.J. Mast cells can enhance resistance to snake and honeybee venoms. Science 2006, 313:526-530.
41. Schneider L.A., Schlenner S.M., Feyerabend T.B., Wunderlin M., Rodewald H.R. Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin. J Exp Med 2007, 204:2629-2639.
42. Maurer M., Wedemeyer J., Metz M., Piliponsky A.M., Weller K., Chatterjea D., Clouthier D.E., Yanagisawa M.M., Tsai M., Galli S.J. Mast cells promote homeostasis by limiting endothelin-1-induced toxicity. Nature 2004, 432:512-516.
43. Tanaka S., Ichikawa A. Recent advances in molecular pharmacology of the histamine systems: immune regulatory roles of histamine produced by leukocytes. J Pharmacol Sci 2006, 101:19-23.
44. Akdis C.A., Simons F.E. Histamine receptors are hot in immunopharmacology. Eur J Pharmacol 2006, 533:69-76.
45. Takagaki K., Osawa S., Horio Y., Yamada T., Hamaya Y., Takayanagi Y., Furuta T., Hishida A., Ikuma M. Cytokine responses of intraepithelial lymphocytes are regulated by histamine H(2) receptor. J Gastroenterol 2009, 44:285-296.
46. McGlade J.P., Gorman S., Lenzo J.C., Tan J.W., Watanabe T., Finlay-Jones J.J., Thomas W.R., Hart P.H. Effect of both ultraviolet B irradiation and histamine receptor function on allergic responses to an inhaled antigen. J Immunol 2007, 178:2794-2802.
47. Furukawa F., Yoshimasu T., Yamamoto Y., Kanazawa N., Tachibana T. Mast cells and histamine metabolism in skin lesions from MRL/MP-lpr/lpr mice. Autoimmun Rev 2009, 8:495-499.
48. Boyce J.A. Eicosanoids in asthma, allergic inflammation, and host defense. Curr Mol Med 2008, 8:335-349.
49. Paz M.L., Ferrari A., Weill F.S., Leoni J., Maglio D.H. Time-course evaluation and treatment of skin inflammatory immune response after ultraviolet B irradiation. Cytokine 2008, 44:70-77.
50. Harizi H., Gualde N. Pivotal role of PGE2 and IL-10 in the cross-regulation of dendritic cell-derived inflammatory mediators. Cell Mol Immunol 2006, 3:271-277.
51. von Bergwelt-Baildon M.S., Popov A., Saric T., Chemnitz J., Classen S., Stoffel M.S., Fiore F., Roth U., Beyer M., Debey S., et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 2006, 108:228-237.
52. Sa-Nunes A., Bafica A., Lucas D.A., Conrads T.P., Veenstra T.D., Andersen J.F., Mather T.N., Ribeiro J.M., Francischetti I.M. Prostaglandin E2 is a major inhibitor of dendritic cell maturation and function in Ixodes scapularis saliva. J Immunol 2007, 179:1497-1505.
53. Sinha P., Clements V.K., Fulton A.M., Ostrand-Rosenberg S. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 2007, 67:4507-4513.
54. Lee S.Y., Choi H.K., Lee K.J., Jung J.Y., Hur G.Y., Jung K.H., Kim J.H., Shin C., Shim J.J., In K.H., et al. The immune tolerance of cancer is mediated by IDO that is inhibited by COX-2 inhibitors through regulatory T cells. J Immunother 2009, 32:22-28.
55. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M., Tsai M. Mast cells as " tunable" effector and immunoregulatory cells: recent advances. Annu Rev Immunol 2005, 23:749-786.
56. Scholten J., Hartmann K., Gerbaulet A., Krieg T., Muller W., Testa G., Roers A. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res 2008, 17:307-315.
57. Musch W., Wege A.K., Mannel D.N., Hehlgans T. Generation and characterization of alpha-chymase-Cre transgenic mice. Genesis 2008, 46:163-166.